Literature DB >> 3211702

Pharmacokinetics of three-dose cefoxitin prophylaxis in caesarean section.

A J Roex1, A C Van Loenen.   

Abstract

A pharmacokinetic analysis of cefoxitin in women undergoing caesarean section under general anaesthesia, was performed. In order to prevent infections postoperatively three doses of cefoxitin--2, 1 and 1 g, respectively--were given as a 3-min intravenous infusion at 6-h intervals. In vitro growth of most pathogens is inhibited at a cefoxitin concentration of 16 micrograms/ml. In the sera of the patients, this antibiotic level was maintained for a period of 90-100 min after the first administration (2 g) and 45-50 min after the second and the third administration of cefoxitin (1 g). The period of subinhibitory antibiotic concentrations lasted 270 and 315 min, respectively. How can one reach prolonged antibiotic coverage? In order to minimize antibiotic pressure on hospital flora it is advisable not to increase the total amount of antibiotic (4 g) administered. By starting a 310 mg/h infusion after the initial 2 g bolus injection, the serum concentration of cefoxitin can be maintained at a minimum level of 16 micrograms/ml during a period of 6.5 h. The improvement of antibiotic administration suggested requires further clinical testing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3211702     DOI: 10.1007/bf02219669

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  12 in total

1.  Single- versus multiple-dose mezlocillin prophylaxis in emergency cesarean section.

Authors:  R Jaffe; M Altaras; R Loebel; N Ben-Aderet
Journal:  Chemotherapy       Date:  1986       Impact factor: 2.544

2.  Single- versus three-dose cefoxitin prophylaxis in caesarean section: a randomized clinical trial.

Authors:  A J Roex; J I Puyenbroek; A C van Loenen; N F Arts
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1987-08       Impact factor: 2.435

3.  Postantibiotic suppression of bacterial growth.

Authors:  R W Bundtzen; A U Gerber; D L Cohn; W A Craig
Journal:  Rev Infect Dis       Date:  1981 Jan-Feb

4.  Comparative pharmacokinetics of cefoxitin in postpartum normotensive and pregnancy-induced hypertensive patients.

Authors:  B Gonik; D Cotton; S Feldman; T G Cleary; L K Pickering
Journal:  Am J Obstet Gynecol       Date:  1984-04-15       Impact factor: 8.661

5.  Single-dose cefotetan versus multidose cefoxitin for prophylaxis in cesarean section in high-risk patients.

Authors:  J A McGregor; J I French; E Makowski
Journal:  Am J Obstet Gynecol       Date:  1986-04       Impact factor: 8.661

6.  Comparison of cefotetan and cefoxitin as prophylaxis in cesarean section.

Authors:  M W Varner; C P Weiner; C R Petzold; R P Galask
Journal:  Am J Obstet Gynecol       Date:  1986-04       Impact factor: 8.661

7.  Short-term antibiotic prophylaxis in high-risk patients following cesarean section.

Authors:  P A Hawrylyshyn; P Bernstein; F R Papsin
Journal:  Am J Obstet Gynecol       Date:  1983-02-01       Impact factor: 8.661

8.  Pharmacokinetics of cefoxitin in patients at term gestation: lavage versus intravenous administration.

Authors:  J F Flaherty; G W Boswell; C A Winkel; J P Elliott
Journal:  Am J Obstet Gynecol       Date:  1983-08-01       Impact factor: 8.661

9.  Single- versus three-dose cefotaxime prophylaxis for cesarean section.

Authors:  B Gonik
Journal:  Obstet Gynecol       Date:  1985-02       Impact factor: 7.661

10.  Systematic approach to the determination of cephalosporins in biological fluids by reversed-phase liquid chromatography.

Authors:  M C Rouan; F Abadie; A Leclerc; F Juge
Journal:  J Chromatogr       Date:  1983-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.